about
Prospects for nucleic acid-based therapeutics against hepatitis C virusIsolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus.Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human VirusesThe hepatitis C virus NS3 protein: a model RNA helicase and potential drug targetNucleic acid aptamers as tools and drugs: recent developments.Recent developments in target identification against hepatitis C virus.Intramers and aptamers: applications in protein-function analyses and potential for drug screening.Understanding helicases as a means of virus control.Gene therapy progress and prospects: RNA aptamers.Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein.RNA as a versatile and powerful platform for engineering genetic regulatory tools.Aptamer-based therapeutics: new approaches to combat human viral diseasesFrameworks for programming biological function through RNA parts and devices.Characterisation of aptamers for therapeutic studies.Aptamers against pathogenic microorganisms.Selection and characterization of RNA aptamers to the RNA-dependent RNA polymerase from foot-and-mouth disease virus.Trans-splicing group I intron targeting hepatitis C virus IRES mediates cell death upon viral infection in Huh7.5 cells.Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.Evolution of an inhibitory RNA aptamer against T7 RNA polymerase.
P2860
Q26852368-3D47A94E-400C-4BF1-8830-C628D6FF767CQ27472976-5807CD09-3556-4852-9C1A-903745DAB3DAQ28079654-C5EDA477-EF29-4B54-996E-73BB0AA0FDA1Q34607601-71E2D8D3-2B64-4E43-8117-945A28C23A29Q35549348-637B524A-21A9-4C38-8F64-3B811EA972F0Q35842500-1A631DEA-17CF-4FD4-8035-B7B4C611FFC1Q36002329-5E628EC7-31BF-4556-88FE-DB1359376916Q36447325-4258C9EB-006D-4690-AD8D-24E767F826B9Q36728599-88868D94-F13A-4179-BBFE-760373795B56Q36939736-050DBAE7-F61A-4BA6-9ABA-71BDD6132168Q37024725-09E08C7C-6920-430F-B78A-581EE6B3E0A1Q37415958-2F681678-C40B-4C0F-A18F-A23E9700B48BQ37422714-E8D02C63-3513-4478-A261-AA545A947EF3Q38089865-8AA6E00E-B586-4275-B621-B3BD8D215823Q38563672-D41B45B6-EDCC-4343-842E-5507C592ECF9Q38880356-97A9C287-8AF2-4B3C-8CD8-ED80E0FA0884Q38891212-7D5F9DB8-4FAA-4724-8803-67A5B735ED3CQ40173025-E7EA574B-2D4A-4FD9-BE17-46238ECE0735Q40318655-7200ADB1-12CC-469A-B4A5-8C16040F6A37
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Inhibition of HCV NS3 protease by RNA aptamers in cells
@ast
Inhibition of HCV NS3 protease by RNA aptamers in cells
@en
Inhibition of HCV NS3 protease by RNA aptamers in cells
@nl
type
label
Inhibition of HCV NS3 protease by RNA aptamers in cells
@ast
Inhibition of HCV NS3 protease by RNA aptamers in cells
@en
Inhibition of HCV NS3 protease by RNA aptamers in cells
@nl
prefLabel
Inhibition of HCV NS3 protease by RNA aptamers in cells
@ast
Inhibition of HCV NS3 protease by RNA aptamers in cells
@en
Inhibition of HCV NS3 protease by RNA aptamers in cells
@nl
P2093
P2860
P356
P1476
Inhibition of HCV NS3 protease by RNA aptamers in cells
@en
P2093
Fumiko Nishikawa
Kohei Funaji
Kotaro Fukuda
Nobuko Kakiuchi
Satoru Sekiya
Satoshi Nishikawa
P2860
P304
P356
10.1093/NAR/GKG291
P407
P577
2003-04-01T00:00:00Z